This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jul 9, 2026
Xaira steps into the spotlight, Vertex spends $10 billion, and investors continue pouring money into select biotech winners.
Jul 7, 2026
Hair loss becomes biotech's hottest investment theme while AI companies inch closer to competing with Big Pharma.
Jul 2, 2026
Claude Science enters the lab, Orca Bio wins FDA approval, and Congress investigates pharma's clinical trial activity in China.
Jun 30, 2026
Moderna launches its first in vivo CAR-T, Merck makes an $11B acquisition, and FDA reversals could reshape rare disease approvals.
Jun 25, 2026
White House denies Trump received Lilly's experimental GLP-1 retatrutide as AbbVie, Lilly and Evaluate reshape biotech's outlook.
Jun 18, 2026
Novo Nordisk rejects multimillion-dollar ransom demands as biopharma dealmaking surges and uniQure moves closer to a Huntington's approval filing.
Jun 16, 2026
A giant liver lands in Philly, Germany backs away from drug pricing reforms, FDA AI adoption accelerates, and biotech professionals debate when hiring will recover.
Jun 11, 2026
GLP-1s may influence depression through the gut while pharma companies look beyond Earth for innovation.
Jun 9, 2026
Researchers get removed from ADA conference after handing out a funding-cuts editorial, while obesity drug developers steal the spotlight in New Orleans.
